|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-03
|
$416,268
|
$416,268
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
$35,002
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$1,240,094
|
$620,047
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
$212,588
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-05
|
$303,240
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Wisconsin NCI Community Oncology Research Program (WiNCORP)
|
5UG1CA189956-05
|
$2,080,158
|
|
ONITILO, ADEDAYO
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
$10,859
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-03
|
$626,868
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
WDR5 as a Critical Co-Factor for MYC
|
5F31CA210429-03
|
$29,196
|
|
FOSHAGE, AUDRA
|
VANDERBILT UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-05
|
$3,106,081
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Viruses and Cancer
|
5T32CA060395-22
|
$156,724
|
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Viral priming and targeting NK cells against solid tumor malignancies
|
5R35CA197292-04
|
$796,220
|
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
Viral Oncology Training Grant
|
5T32CA009111-40
|
$391,340
|
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
$65,611
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-03
|
$341,981
|
$341,981
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
|
5UG1CA189869-05
|
$1,196,666
|
|
GEYER, CHARLES
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Variant identification for cancer genomics
|
1R15CA220059-01A1
|
$447,460
|
|
GRIGORIEV, ANDREY
|
RUTGERS THE STATE UNIV OF NJ CAMDEN
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-03
|
$39,076
|
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$25,171
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-19
|
$961,183
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-04
|
$394,823
|
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-03
|
$386,051
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
5R01CA217625-02
|
$635,068
|
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UW Radiological Sciences Training Program
|
5T32CA009206-40
|
$499,580
|
|
HALL, TIMOTHY
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$137,704
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$7,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$4,087
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$2,271
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$953
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
|
5R01CA183962-04
|
$603,232
|
|
HERNANDEZ-BOUSSARD, TINA
|
STANFORD UNIVERSITY
|
|
Utility of RAS mimetics to block oncogenic signaling in colorectal cancer
|
1R21CA227963-01
|
$221,198
|
|
REDDY, E
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
$8,062
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
$15,845
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
USP22 Function in Advanced Prostate Cancer
|
5R01CA182569-04
|
$493,498
|
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
5R01CA210259-02
|
$667,691
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
|
5U01CA199216-04
|
$623,508
|
|
JACKSON, PETER
|
STANFORD UNIVERSITY
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-03
|
$38,124
|
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Using Context to Improve Implementation of Evidenced-based Interventions for Colorectal Cancer Screening in Rural Primary Care (Precise CRC)
|
5K07CA211971-02
|
$170,636
|
|
DAVIS, MELINDA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$1,218
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$188,054
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-19
|
$302,547
|
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
5R01CA190642-04
|
$436,922
|
|
SCALTRITI, MAURIZIO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unmet needs for specific subsets of EGFR mutated lung cancer
|
1R37CA218707-01A1
|
$409,171
|
|
COSTA, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
University of Washington/Fred Hutch Center for AIDS Research
|
2P30AI027757-31
|
$508,801
|
|
BAETEN, JARED
|
UNIVERSITY OF WASHINGTON
|
|
University of Rochester-NCORP Research Base
|
5UG1CA189961-05
|
$4,001,073
|
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
Total relevant funding to Liver Cancer for this search: $111,169,058
|